[{"Assets_0_Q2_USD":1520685000.0,"CommonStockSharesOutstanding_0_Q2_shares":86642000.0,"EarningsPerShareBasic_1_Q2_USD":1.25,"EarningsPerShareBasic_2_Q2_USD":2.27,"EarningsPerShareDiluted_1_Q2_USD":1.23,"EarningsPerShareDiluted_2_Q2_USD":2.23,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":153728000.0,"NetIncomeLoss_1_Q2_USD":108691000.0,"NetIncomeLoss_2_Q2_USD":198142000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":580752000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":1118408000.0,"StockholdersEquity_0_Q2_USD":-41127000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":88596000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":88786000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":87004000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":87166000.0,"Ticker":"IDXX","CIK":"874716","name":"IDEXX LABORATORIES INC \/DE","OfficialName":"IDEXX Laboratories Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"42180715521.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"SP500","filed":"20180801"}]